Replavite and Urinary retention - from FDA reports
Urinary retention is reported only by a few people who take Replavite. We study 104 people who have side effects while taking Replavite from FDA. Among them, 1 have Urinary retention. Find out below who they are, when they have Urinary retention and more.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Jul, 17, 2017
104 people reported to have side effects when taking Replavite.
Among them, 1 person (0.96%) has Urinary retention
Number of reports submitted per year:
Gender of people who have Urinary retention when taking Replavite *:
- female: 0.0 %
- male: 100 %
Age of people who have Urinary retention when taking Replavite *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Top conditions involved for these people *:
- Dialysis (1 person, 100.00%)
Top co-used drugs for these people *:
- Simvastatin (1 person, 100.00%)
- Plavix (1 person, 100.00%)
- Nitrolingual (1 person, 100.00%)
- Extraneal (1 person, 100.00%)
- Aranesp (1 person, 100.00%)
Top other side effects for these people *:
- Heart Attack (1 person, 100.00%)
- Cerebrovascular Stenosis (1 person, 100.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Urinary retention when taking Replavite?
Replavite has active ingredients of ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; pyridoxine hydrochloride; riboflavin phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e. (latest outcomes from Replavite 107 users)
Urinary retention (the inability to completely or partially empty the bladder) has been reported by people with multiple sclerosis, high blood pressure, depression, pain, chronic obstructive pulmonary disease (latest reports from 21,937 Urinary retention patients).